JESSICA DIGIORGIO: Open Payments
NPI 1639950967 · PALMYRA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 28 payments from 10 companies in 2025. Trend: 2023 $148 · 2024 $440 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $196 |
| PFIZER INC. | 4 | $84 |
| Lilly USA, LLC | 3 | $59 |
| Novo Nordisk Inc | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $23 |
| KYOWA KIRIN, INC. | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
Products named: VRAYLAR, QULIPTA, NURTEC ODT, Wegovy, Auvelity, ELIQUIS, MOUNJARO, REXULTI.
Industry payments across VA — which companies pay providers there.
